Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity

被引:27
作者
Chhabra, Yash [1 ,4 ]
Nelson, Caroline N. [4 ]
Plescher, Monika [4 ,5 ]
Barclay, Johanna L. [2 ,4 ]
Smith, Aaron G. [3 ]
Andrikopoulos, Sof [6 ]
Mangiafico, Salvatore [6 ]
Waxman, David J. [7 ]
Brooks, Andrew J. [1 ,4 ]
Waters, Michael J. [4 ]
机构
[1] Univ Queensland, Diamantina Inst, Translat Res Inst, 37 Kent St, Brisbane, Qld 4102, Australia
[2] Univ Queensland, Mater Res Inst, Translat Res Inst, Brisbane, Qld, Australia
[3] Univ Queensland, Sch Biomed Sci, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia
[4] Univ Queensland, Inst Mol Biosci, 306 Carmody Rd, Brisbane, Qld 4072, Australia
[5] Univ Bonn, Med Fac, Inst Cellular Neurosci, Bonn, Germany
[6] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[7] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
metabolism; gluconeogenesis; hepatic glucose output; SKELETAL-MUSCLE; HEPATIC GLUCONEOGENESIS; GENE-EXPRESSION; NEGATIVE REGULATOR; RECEPTOR SUBSTRATE-1; TARGETED DISRUPTION; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; LARON SYNDROME; FATTY LIVER;
D O I
10.1096/fj.201802328R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growth hormone (GH) has an important function as an insulin antagonist with elevated insulin sensitivity evident in humans and mice lacking a functional GH receptor (GHR). We sought the molecular basis for this sensitivity by utilizing a panel of mice possessing specific deletions of GHR signaling pathways. Metabolic clamps and glucose homeostasis tests were undertaken in these obese adult C57BL/6 male mice, which indicated impaired hepatic gluconeogenesis. Insulin sensitivity and glucose disappearance rate were enhanced in muscle and adipose of mice lacking the ability to activate the signal transducer and activator of transcription (STAT)5 via the GHR (Ghr-391(-/-)) as for GHR-null (GHR(-/-)) mice. These changes were associated with a striking inhibition of hepatic glucose output associated with altered glycogen metabolism and elevated hepatic glycogen content during unfed state. The enhanced hepatic insulin sensitivity was associated with increased insulin receptor and insulin receptor substrate 1 activation along with activated downstream protein kinase B signaling cascades. Although phosphoenolpyruvate carboxykinase (Pck)-1 expression was unchanged, its inhibitory acetylation was elevated because of decreased sirtuin-2 expression, thereby promoting loss of PCK1. Loss of STAT5 signaling to defined chromatin immunoprecipitation targets would further increase lipogenesis, supporting hepatosteatosis while lowering glucose output. Finally, up-regulation of IL-15 expression in muscle, with increased secretion of adiponectin and fibroblast growth factor 1 from adipose tissue, is expected to promote insulin sensitivity.Chhabra, Y., Nelson, C. N., Plescher, M., Barclay, J. L., Smith, A. G., Andrikopoulos, S., Mangiafico, S., Waxman, D. J., Brooks, A. J., Waters, M. J. Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity.
引用
收藏
页码:6412 / 6430
页数:19
相关论文
共 77 条
[1]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[2]   Increased p85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess [J].
Barbour, LA ;
Rahman, SM ;
Gurevich, I ;
Leitner, JW ;
Fischer, SJ ;
Roper, MD ;
Knotts, TA ;
Vo, Y ;
McCurdy, CE ;
Yakar, S ;
LeRoith, D ;
Kahn, CR ;
Cantley, LC ;
Friedman, JE ;
Draznin, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (45) :37489-37494
[3]   GH-Dependent STAT5 Signaling Plays an Important Role in Hepatic Lipid Metabolism [J].
Barclay, Johanna L. ;
Nelson, Caroline N. ;
Ishikawa, Mayumi ;
Murray, Lauren A. ;
Kerr, Linda M. ;
McPhee, Timothy R. ;
Powell, Elizabeth E. ;
Waters, Michael J. .
ENDOCRINOLOGY, 2011, 152 (01) :181-192
[4]   Comparing adiposity profiles in three mouse models with altered GH signaling [J].
Berryman, DE ;
List, EO ;
Coschigano, KT ;
Behar, K ;
Kim, JK ;
Kopchick, JJ .
GROWTH HORMONE & IGF RESEARCH, 2004, 14 (04) :309-318
[5]   Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction [J].
Bonkowski, Michael S. ;
Rocha, Juliana S. ;
Masternak, Michal M. ;
Al Regaiey, Khalid A. ;
Bartke, Andrzej .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (20) :7901-7905
[6]   EFFECTS OF HYPOPITUITARISM AND GROWTH-HORMONE REPLACEMENT THERAPY ON THE PRODUCTION AND UTILIZATION OF GLUCOSE IN CHILDHOOD [J].
BOUGNERES, PF ;
ARTAVIALORIA, E ;
FERRE, P ;
CHAUSSAIN, JL ;
JOB, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (06) :1152-1157
[7]   SIRT1 metabolic actions: Integrating recent advances from mouse models [J].
Boutant, Marie ;
Canto, Carles .
MOLECULAR METABOLISM, 2014, 3 (01) :5-18
[8]   Interleukin-15 increases glucose uptake in skeletal muscle -: An antidiabetogenic effect of the cytokine [J].
Busquets, Silvia ;
Figueras, Maite ;
Almendro, Vanessa ;
Lopez-Soriano, Francisco J. ;
Argiles, Josep M. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (11) :1613-1617
[9]   AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity [J].
Canto, Carles ;
Gerhart-Hines, Zachary ;
Feige, Jerome N. ;
Lagouge, Marie ;
Noriega, Lilia ;
Milne, Jill C. ;
Elliott, Peter J. ;
Puigserver, Pere ;
Auwerx, Johan .
NATURE, 2009, 458 (7241) :1056-U140
[10]   Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5 [J].
Caton, Paul W. ;
Nayuni, Nanda K. ;
Kieswich, Julius ;
Khan, Noorafza Q. ;
Yaqoob, Muhammed M. ;
Corder, Roger .
JOURNAL OF ENDOCRINOLOGY, 2010, 205 (01) :97-106